Bayesian Capital Management LP Grows Position in Bath & Body Works, Inc. (NYSE:BBWI)

Bayesian Capital Management LP lifted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 42.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,524 shares of the company’s stock after purchasing an additional 13,600 shares during the quarter. Bayesian Capital Management LP’s holdings in Bath & Body Works were worth $2,277,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. SG Americas Securities LLC lifted its stake in Bath & Body Works by 18.0% in the 4th quarter. SG Americas Securities LLC now owns 17,860 shares of the company’s stock valued at $771,000 after buying an additional 2,724 shares in the last quarter. Denali Advisors LLC acquired a new position in Bath & Body Works in the 4th quarter valued at $27,000. Fifth Third Bancorp raised its stake in Bath & Body Works by 20.4% in the 4th quarter. Fifth Third Bancorp now owns 20,822 shares of the company’s stock valued at $899,000 after purchasing an additional 3,526 shares during the last quarter. Princeton Global Asset Management LLC acquired a new stake in Bath & Body Works during the 4th quarter worth $43,000. Finally, China Universal Asset Management Co. Ltd. raised its position in shares of Bath & Body Works by 116.8% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 19,305 shares of the company’s stock valued at $833,000 after buying an additional 10,400 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Trading Up 3.2 %

Shares of NYSE BBWI traded up $1.14 during mid-day trading on Tuesday, reaching $36.27. The company had a trading volume of 1,806,519 shares, compared to its average volume of 2,903,597. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $52.99. The stock has a market cap of $8.10 billion, a P/E ratio of 9.35, a PEG ratio of 1.13 and a beta of 1.85. The firm has a 50 day simple moving average of $41.77 and a two-hundred day simple moving average of $44.24.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Tuesday, June 4th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.05. The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.37 billion. Bath & Body Works had a negative return on equity of 40.00% and a net margin of 11.92%. The business’s revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.33 earnings per share. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.29 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 21st. Investors of record on Friday, June 7th were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend was Friday, June 7th. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.62%.

Analysts Set New Price Targets

Several analysts recently issued reports on BBWI shares. Wells Fargo & Company dropped their price objective on shares of Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 24th. JPMorgan Chase & Co. raised Bath & Body Works from an “underweight” rating to a “neutral” rating and boosted their price objective for the stock from $40.00 to $53.00 in a research note on Friday, May 17th. Telsey Advisory Group restated an “outperform” rating and issued a $53.00 target price on shares of Bath & Body Works in a report on Tuesday, June 4th. BMO Capital Markets lifted their price target on Bath & Body Works from $50.00 to $55.00 and gave the stock an “outperform” rating in a report on Wednesday, June 5th. Finally, Piper Sandler dropped their price objective on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $47.60.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.